$0.802
-0.012 (-1.47%)收盤時
DH 資訊
DH 事件
Consensus 18c Narrows FY26 Revenue Outlook to $220M
Consensus 18c. Narrows FY26 revenue view to $220M from $220M-$226M, consensus $223.45M. Sees FY26 adjusted EBITDA view $57M-$59M.
Definitive Healthcare Q2 Revenue at $55.2M
Reports Q2 revenue $55.2M, consensus $55.39M. "Definitive Healthcare delivered another quarter in line with or above our guidance ranges, reflecting continued discipline alongside targeted investment in our growth priorities," said Kevin Coop, CEO of Definitive Healthcare. "We're encouraged by our second consecutive quarter of year-over-year improvement in net dollar retention, strong win-back momentum across our end markets, and the launch of Turbo, our new AI-powered healthcare intelligence platform, which marks a significant milestone in our innovation strategy. We remain confident that our focus on data quality and customer success is the right path to return to sustained, predictable growth, while continuing to generate strong profitability and cash flow."
Sees Q3 Revenue of $54M-$55M
Sees Q3 revenue $54M-$55M, consensus $55.38M. Sees Q3 adjusted EBITDA $13.5M-$14.5M.
Definitive Healthcare Q1 Revenue $55.93M, Exceeds Expectations
Reports Q1 revenue $55.93M, consensus $54.98M. "Definitive Healthcare started 2026 on a solid note, with financial results at or above the high end of our guidance ranges. We continue to make progress against each of our strategic pillars and are realizing some positive early indications of success, including improvements in retention rates," said Kevin Coop, CEO of Definitive Healthcare. "We remain confident we are making the right investments to drive sustained long-term operational and financial improvements, while also continuing to generate significant profitability and cash flow."
Company Confirms FY26 Revenue Outlook of $220M to $226M
Consensus 17c. Backs FY26 revenue view $220M-$226M, consensus $223.64M. Backs FY26 adjusted EBITDA view $13.5M-$14.5M.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。